Filters by
Month -
Specialty +
- All Specialties
- trauma5
- cardiology4
- orthopedics3
- medicine2
- nursing2
- oncology2
- metabolism and diabetes1
- anesthesiology1
- asthma clinical immunology1
- burn surgery1
- cardiothoracic surgery1
- critical care medicine1
- emergency medical technician1
- emergency medicine1
- endocrinology1
- gastroenterology1
- genetics1
- hematology blood and marrow transplant1
- hepatology1
- immunology and microbiology1
Country +
City +
Conference Type +
Free Conference
- Free Conference
CME Points
Upcoming Medical Conferences in La Jolla
Search Criteria : United States of America La Jolla
Feb 23, 2019 | CME 4.50
| La Jolla, California
.png)
497
6
Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension is organized by Scripps Health and will be held on Feb 23, 2019 at Schaetzel Center, La Jolla, California, United States of America.
The target audience for this medical event is Cardiologists, Internists, Primary Care Practitioners, Nurses, Nurse Practitioners, Physician Assistants. This CME Conference has been approved for a maximum of 4.5 AMA PRA Category 1 Credits.
Conference Description:
This CME conference is designed to educate clinicians on state-of-the-art care for pulmonary hypertension.
Pulmonary hypertension (PH) is a common and widely misunderstood syndrome that results from a surprisingly large number of disease processes. It can occur at any age and the risk of developing PH increases with age and other medical conditions. Great strides have been made in the past 15 years in diagnosing and treating pulmonary arterial hypertension (PAH) so that the natural history of PAH is rapidly changing. On the other hand, the more common clinical variant, pulmonary venous hypertension (PVH) has been largely unaffected by medical therapy. In addition, there is often a divide between those whose treat PAH and those clinicians whose patients have PVH and are frustrated by the lack of effective therapy.
This conference will be unique in that it will cover all forms of pulmonary hypertension. Expert faculty will discuss the epidemiology of PH, how PH is diagnosed, and the poor outcomes associated with PH when left untreated. Clinicians will leave with a better understanding of the difference between PAH and PVH and why the difference matters. Therapies for PAH and PVH will also be discussed with reference to current clinical guidelines. Participants will return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.
Conference Objectives are:
• Describe the epidemiology and pathophysiology of pulmonary hypertension.
• Determine who is at risk for pulmonary hypertension and effectively diagnose patients.
• Recognize the difference between PAH and PVH and how this translates into therapy.
• Outline the current approach to pulmonary hypertension treatment in the presence of related or underlying diseases.
• Evaluate current pharmacologic and medical management strategies for patients with pulmonary hypertension.
• Incorporate novel therapies into patient care for improved outcomes.
Identify when to refer patients for specialty treatment.
Prices:
Physicians: USD 100.0
Non-Physicians: USD 65.0
Speakers: J. Thomas Heywood, MD, FACC, Laith Alshawabkeh, MD, FACC, Steven J. Escobar, MD, Richard M. Keating, MD, Rajeev C. Mohan, MD, Demosthenes Papamatheakis, MD, Ajay V. Srivastava, MD, FACC
Time: 7:30 am - 1:10 pm
Mar 03 - 06, 2019
| La Jolla, California
.png)
514
0
Advanced Course in Basic & Clinical Immunology is organized by Federation of Clinical Immunology Societies (FOCIS) and will be held from Mar 03 - 06, 2019 at Estancia La Jolla, La Jolla, California, United States of America.
Target Audience:
This course is designed for:
• Clinical fellows in disciplines related to immunology, including rheumatology, allergy, infectious disease, oncology and transplantation
• Fellows doing basic research with an emphasis on human disease
• Scientists or other research and development personnel from biotechnology and pharmaceutical companies who are involved in developing new therapies for immunological disease
• Academic or community physicians who wish to enhance their understanding of immunology
Course Description :
The lectures cover the major topics in cellular and molecular immunology, including innate immunity, B cells, T cells, dendritic cells, cytokines and mucosal immunity. Other lectures cover autoimmune, allergic and immunodeficiency diseases, as well as new advances in interventional and clinical immunology and the molecular and genetic basis of immunologically-mediated diseases.
All lecturers encourage interaction with the students through questions and discussions during lecture time. There is also ample opportunity for students to interact with the faculty outside the lecture room.
Learning Objectives:
At the conclusion of this course, attendees will be able to:
• Discuss the fundamental mechanisms underlying protective immune responses, and discuss the recent advances and emerging themes in immunology research.
• Describe the fundamental mechanisms underlying immunologic disease and associate these mechanisms with strategies for therapeutic modulation of the immune system.
• Appreciate the basic immunological principles underlying biotherapeutics, recognize the commonality among diverse organ-specific disease states and infer the mechanisms of therapeutic effect.
• Analyze the medical literature reporting immunologic advances pertinent to their patients, cite the rationale for use of new immunodiagnostic and immunotherapeutic modalities in their patients, and serve as thought leaders within their medical communities.
Mar 08 - 10, 2019 | CME 13.50
| USD $375
| La Jolla, California
.png)
609
12
34th Annual New Treatments in Chronic Liver Disease CME Conference is organized by Scripps Conference Services & CME and will be held from Mar 08 - 10, 2019 at Estancia La Jolla Hotel & Spa, La Jolla, California, United States of America.
The target audience for this medical event is Hepatologists, Gastroenterologists, Infectious Disease Specialists, Nurse Practitioners, Physician Assistants, Nurses, Residents/Fellows. This CME Conference has been approved for a maximum of 13.50 AMA PRA Category 1 Credits.
Course Overview :
This CME conference will review new medications and therapies that are now available, or will soon be available, and discuss their comparative values. The results of trials using new drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, cholangiocarcinoma, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.
There was a fundamental change in the treatment of chronic hepatitis C in late 2014 with the addition of multiple new direct-acting antiviral (DAAs) drugs to current standard of care for all genotypes. There will be two separate lectures devoted to this topic this year. The first will be on currently available all-oral therapies that have been approved and are currently in use. The second will be on the benefits of cure and post-cure management of patients with cirrhosis. In addition, the pre-conference will extensively detail currently available treatment regimens with the goal of introducing the topic to new treaters.
In this past year, new treatments have been reported for both Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC). For this reason, we have invited Dr.
Cynthia Levy, Assistant Director of the Schiff Center for Liver Diseases at the University of Miami, Miller School of Medicine to act as our William S. Haubrich Memorial Lecturer on these topics. The course will also review alcoholic liver disease and NASH, which have now surpassed chronic hepatitis C as the leading indications for liver transplantation in the United States. We have invited a world-recognized expert on alcoholic liver disease to update our knowledge of the topic this year.
Although hepatitis B treatments have not changed, we now have more mature data available on long-term HBsAg loss and clinical outcomes. The addition of immune-mediated therapies for HBV with the goal of curing the disease will also be included in this year’s program. New therapies for NAFLD and NASH are in development and important new data showing positive results in NASH will be presented at this meeting, including the first results of a phase 3 global treatment trial. The explosive growth of NASH in the United States has created a significant need for effective drug therapy. A number of new systemic therapies for HCC that have been approved in the last two years will also be discussed. In addition, the course will provide updates on management of hepatic encephalopathy, hyponatremia, thrombocytopenia, and complications in the transplant candidate.
Conference Objectives :
• Understand the details of the AASLD guidelines for treatment of HCV using DAA’s in IFN-free regimens.
• Review our current knowledge of NAFLD and non-alcoholic steatohepatitis and explore the use of new agents and approaches to treatment of the conditions.
• Integrate the algorithm for a therapeutic approach to treatment of HBV using anti-virals.
• Discuss therapies for HCV including NS5A, protease and polymerase inhibitors.
• Update the skills and management required for transplant hepatology.
• Apply current options of therapy for hepatocellular carcinoma to determine the best approach for your patients.
• Discuss future treatment paradigms for HCV direct-acting antiviral drug.
• Describe the diagnosis and treatment of PBC and PSC.
• Integrate treatment options discussed for patients with ESLD due to alcohol who have complicating factors such as HCV, NASH or inherited genetic disorder.
• Discuss the issues complicating drug treatment in decompensated cirrhosis, hepatic encephalopathy and hyponatremia.
• Review the management of complications beta-blocker therapy in ESLD.
Conference Highlights :
• Half day pre-conference seminar reviewing the virology, genotypes and modes of infection of HCV
• Plenary talks from nationally recognized experts
• Presentations on hot topics, upcoming scientific developments, and current advances in in chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease
• Networking opportunities among colleagues
• Conference app with access to course materials and recordings from the convenience of your mobile device or computer
Time: 12:30 to 11:30
Speakers: Paul J. Pockros, MD, FACG, Scripps Clinic , Catherine T. Frenette, MD, FAST, AGAF, Scripps Clinic , Terry D. Box, MD, University of Utah School of Medicine, Paul Kwo, MD, Stanford University Medical Center, Cynthia Levy, MD, FAASLD, University of Miami, Miller School of Medicine, Michael R. Lucey, MD, University of Wisconsin School of Medicine and Public Health, Christian B. Ramers, MD, San Diego State University, School of Public Health, Yuki Rosenkoetter, PAC, MPAS, Scripps Clinic, Baylor College of Medicine, Norman L. Sussman, MD, Baylor College of Medicine, I. Raymond Thomason, MD, University of Utah, Zobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD, Inova Fairfax Hospital Center for Liver Disease
Mar 14 - 15, 2019
| USD $450
| La Jolla, California
.png)
37
23
Future of Individualized Medicine is organized by Scripps Research Translational Institute and will be held from Mar 14 - 15, 2019 at Scripps Institution of Oceanography, La Jolla, California, United States of America.
Description:
After 11 annual conferences exploring genomic medicine, we’re broadening our scope.
In 2019, the newly renamed Future of Individualized Medicine(formerly Future of Genomic Medicine) conference will expand to include additional perspectives on how to tailor medicine to the individual. Individualized medicine takes into account a person’s genes-and genomics will remain a core topic for exploration and discussion-but it also considers the full spectrum of a person’s uniqueness from their biologic, physiologic, anatomic, lifestyle and environmental information. The Future of Individualized Medicine conference will thus incorporate perspectives from the emerging fields of digital medicine, artificial intelligence and machine learning, behavioural science and others. This is truly a multidisciplinary forum designed to accelerate the transformation of medicine.
Attendees at the 2019 conference will again hear renowned leaders from academia, industry, and science and medical journalism speak on the most recent innovations and trends. Patients will also share stories of the impact individualized medicine has had on their personal health journey.
Conference Registration Questions:
Melissa M. Kocias, Institute Registrar
Indiana University Conferences, IU Bloomington
Phone: 812-855-4224
Email: iuconfs@indiana.edu
General Conference Questions:
Karin L. Reece, Conference Coordinator
Indiana University Conferences, IU Bloomington
Phone: 812-856-5221
Email: kreece@indiana.edu
Additional details will be posted as soon as they are available.
Apr 04 - 07, 2019
| La Jolla, California
.png)
66
0
AOTrauma Course - Advanced Principles of Fracture Management is organized by AOTrauma and will be held from Apr 04 - 07, 2019 at La Jolla, California, United States of America.
Additional details will be posted as soon as they are available.
Apr 04 - 07, 2019
| USD $1600
| La Jolla, California
.png)
58
0
AOTrauma Course - Basic Principles of Fracture Management is organized by AOTrauma North America and will be held from Apr 04 - 07, 2019 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.
This Basic Principles of Fracture Management course is designed to provide the participant with a fundamental knowledge of the operative treatment of fractures according to the AO principles.
The four guiding AO principles of fracture fixation are:
• Anatomic reduction of the fracture fragments, particularly in joint fractures;
• Stable fixation to ensure proper healing of the fracture while allowing surrounding tissue to move and strengthen;
• Atraumatic surgical techniques to preserve the blood supply to the bone fragments and soft tissue;
• Early, pain-free mobilization returning the patient to function as quickly as possible.
This course will also cover the concepts of absolute and relative stability of soft tissue injury as applied, in context, for each limb segment’s major fracture types.
This course is the foundation for the AO North America curriculum, which teaches the surgeon how to manage trauma and trauma reconstruction. The goal of this course is not to advocate the treatment of all fractures by surgical fixation, but rather, to help ensure that when surgery is carried out, that it is done properly based upon principles, appropriate preoperative planning, and decision making.
Learner Objectives:
Upon completion, participants should be able to:
• Discuss the concepts of stability, their influence on bone healing, and how to apply implants to achieve appropriate stability
• Plan a treatment based on assessment, imaging, classification, and decision making
• Apply reduction techniques in fracture management with attention to the importance of the soft-tissue
• Apply related psychomotor skills to the practical application of orthopedic implants to fractured bones
• Plan the initial treatment of the polytraumatized patient
Additional details will be posted as soon as they are available.
Apr 04 - 07, 2019
| USD $1600
| La Jolla, California
.png)
224
0
Trauma Basic Principles is organized by AO North America and will be held from Apr 04 - 07, 2019 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.
Course Summary:
This Basic Course is designed to provide the participant with a fundamental knowledge of the operative treatment of fractures according to the AO principles. The four guiding AO principles of fracture fixation are:
• Anatomic reduction of the fracture fragments, particularly in joint fractures
• Stable fixation to ensure proper healing of the fracture allowing surrounding tissue to move and strengthen
• Atraumatic surgical technique to preserve the blood supply to the bone fragments and soft tissue
• Early, pain-free mobilization returning the patient to function as soon as possible.
The course will cover the concepts of absolute and relative stability, as applied in context, of the soft tissue injury for each limb segment’s major fracture types. This course is the foundation for the AONA curriculum, which teaches the surgeon how to manage trauma and trauma reconstruction. The goal of this course is not to advocate the treatment of all fractures by surgical fixation, but rather to help ensure that when surgery is carried out, that it is done properly based upon principles, appropriate preoperative planning, and decision making.
Learning Objectives:
Upon completion, participants should be able to:
• Discuss the concepts of stability, their influence on bone healing, and how to apply implants to achieve appropriate stability
• Plan a treatment based on assessment, imaging, classification, and decision making
• Apply reduction techniques in fracture management with attention to the importance of the soft-tissue
• Apply related psychomotor skills to the practical application of orthopedic implants to fractured bones
• Plan the initial treatment of the polytraumatized patient
Additional details will be posted as soon as they are available.
Apr 04 - 07, 2019 | CME 27.00
| USD $1695
| La Jolla, California
.png)
204
0
Trauma Advanced Principles is organized by AO North America and will be held from Apr 04 - 07, 2019 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.
Designation Statement:
AO North America designates this live educational activity for a maximum of 27.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Course Summary:
This Advanced Course will focus on the treatment of complex fractures and fracture complications. This will be accomplished through didactic presentations and group discussions between the participants and faculty. In addition, surgical techniques will be practiced on artificial bones. Topics will include complex fractures of the upper and lower extremities, fractures of the pelvis and acetabulum, fracture complications and polytrauma management. Participants will have the opportunity to address the treatment of malunions and nonunions, using preoperative planning and current fixation technique.
This course also provides valuable, hands-on experiences through the opportunity to practice newly learned surgical techniques on artificial bones. Participants will use preoperative planning and the latest fixation techniques to address the treatment of malunions and nonunions.
Prerequisite: The AO Basic Principles of Fracture Management course is a prerequisite for the Advanced Principles of Fracture Management course as familiarity and competence with instrumentation and techniques will be assumed.
Learning Objectives:
Upon completion, participants should be able to:
• Apply reduction techniques in fracture management with attention to soft tissue
• Assess and treat complex diaphyseal and (peri)articular fractures using advanced application techniques
• Demonstrate strategies for assessing and treating open fractures and soft-tissue injuries
• Initiate appropriate management for patients with pelvic injuries and polytrauma
• Recognize complications and manage accordingly
Apr 12 - 14, 2019 | CME 15.00
| USD $450
| La Jolla, California
.png)
371
15
Sixth Annual Clinical Advances in Heart Failure and Arrhythmias is organized by Scripps Health and will be held from Apr 12 - 14, 2019 at San Diego Marriott La Jolla, La Jolla, California, United States of America.
Accreditation
Physicians:
Scripps Health designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants
PAs may claim a maximum of 15 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Target Audience:
• Cardiologists
• Electrophysiologists
• Internists
• Cardiology Nurses/Nurse Practitioners
• Cardiology Physician Assistants
• Cardiovascular Technicians
Conference Description :
Significant advances in the diagnosis and management of heart failure and arrhythmias continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these cardiovascular conditions. Expert faculty will cover a wide range of topics including the diagnosis, management, and state-of-the-art treatment for heart failure and cardiac arrhythmias. Participants will return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.
Educational Objectives:
After attending this live activity, participants should be able to:
• Incorporate current and emerging clinical evidence in the assessment, treatment and management of patients with challenging cardiovascular disease.
• Apply new concepts in the management of arrhythmias, heart failure and hypertension.
• Employ new medical and surgical therapies for heart failure.
• Discuss current pharmacologic and medical management strategies for patients with atrial fibrillation.
• Assess device based therapies for heart rhythm disorders.
• Enhance skills in the management of cardiovascular disease in women.
• Illustrate techniques to aid in patient adherence to prescribed medications.
• Describe current pharmacologic and medical management strategies for patients with chemo-induced cardiomyopathy.
• Identify appropriate treatments for peripheral vascular disease.
• Determine the effect of comorbidity and chronic conditions on patients with heart disease.
• Outline best practices for the management of patients with atrial fibrillation.
• Integrate new guidelines for hypertension and heart failure management into practice.
Conference Highlights :
• Plenary talks from nationally recognized experts
• Presentations on hot topics, upcoming scientific developments, and current advances in treatment for heart failure and arrhythmias
• In-depth breakout sessions on pertinent topics
• Networking opportunities among colleagues
• Conference app with access to course materials and recordings from the convenience of your mobile device or computer
Time: 07:00 to 11:30
Speakers: Douglas N. Gibson, MD, FHRS, J. Thomas Heywood, MD, FACC, John D. Rogers, MD, FACC, , Daniel Einhorn, MD, FACP, FACE, M. Edip Gurol, MD, MSc, Joseph C. Marek, MD, FACC, Christian W. Mende, MD, FACP, FACN, FASN, FASH
May 04, 2019 | CME 8.00
| USD $250
| La Jolla, California
.png)
11
0
Inaugural Point of Care Ultrasound (POCUS) Course is organized by Scripps Conference Services & CME and will be held on May 04, 2019 at Schaetzel Center, La Jolla, California, United States of America.
Accreditation:
Physicians:
Scripps Health designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Academy of Physician Assistants:
PAs may claim a maximum of 8 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Course Description :
The Inaugural Scripps Point of Care Ultrasound (POCUS) Course is designed to demonstrate the benefits of employing point of care ultrasound technology at the bedside to gain real time diagnostic information. This will empower healthcare providers to make the best and most appropriate decisions about next treatments and interventions for their patients. Ultrasound can be used to diagnose many conditions (cardiovascular, lung, and abdominal pathologies) and to guide various interventions (vascular access, thoracentesis, and paracentesis). POCUS is particularly beneficial when patients present unstable or when they develop instability in an acute setting. In these scenarios providers can use ultrasound at the bedside to assess and diagnosis critical conditions such as cardiac tamponade, tension pneumothorax, or aortic dissection. Prompt diagnosis of such critical conditions can lead to improved patient outcomes, decreased lengths of hospital stay, and decreased overall costs of care.
Course Objectives:
After attending this live activity, participants should be able to:
• Comfortably operate a point of care ultrasound machine with the ability to select the proper probe, pick the correct exam type and use simple controls to enhance image resolution.
• Obtain clear images of different anatomical structures of the body and recognize normal anatomy and diagnose basic critical pathology.
• Demonstrate knowledge of the general terms used when describing an ultrasound study (anechoic, echogenic and acoustic shadowing)
• Identify important types of ultrasound artifacts and their role in image acquisition.
• Develop proficiency in the performance and interpretation of basic and advanced point-of-care ultrasound examinations.
• Demonstrate different exam protocols to help quickly diagnose critical pathology and allow for rapid treatment decisions in regards to patient care.
• Illustrate how to use ultrasound to better guide invasive patient procedures such as vascular access, thoracentesis, paracentesis, and soft tissue infections.
Additional details will be posted as soon as they are available.